Mit MOR und NRI gegen „Mixed pain“

CME ◽  
2013 ◽  
Vol 10 (7-8) ◽  
pp. 56-56
Keyword(s):  
2012 ◽  
Vol 31 (03) ◽  
pp. 147-153 ◽  
Author(s):  
M. Förster ◽  
F. Mahn ◽  
R. Baron

ZusammenfassungDas aktuelle Konzept für chronische Rückenschmerzen postuliert ein Nebeneinander von nozizeptiven und neuropathischen Schmerzkomponenten (Mixed-Pain-Konzept). Die charakteristischen neuropathischen Symptome mit negativen und positiven Phänomenen helfen bei der Diagnosestellung. Durch weitgehend objektive Verfahren wie Bedside-Tests und Fragebögen kann die neuropathische Komponente valide identifiziert werden. Für die therapeutischen Optionen stehen nur Daten für den nozizeptiven Rückenschmerz zur Verfügung. In Anlehnung an klassische neuropathische Schmerzsyndrome versucht man einen Ansatz mit Medikamenten, ohne dass eine spezifische evidenzbasierte Therapie empfohlen werden kann.


2021 ◽  
Author(s):  
Fatme Hoteit ◽  
Debbie Erhmann Feldman ◽  
Lisa C. Carlesso

Purpose: To explore factors associated with intermittent, constant, and mixed pain in people with knee osteoarthritis. Method: We conducted a secondary analysis of a cross-sectional multicenter study with adults ≥ 40 years with knee osteoarthritis. Participants completed questionnaires on personal (e.g., demographics, comorbidities), physical (e.g., physical function), psychological (e.g., depressive symptoms), pain (e.g., qualities), and tests for physical performance and nervous system sensitivity. We qualified patients’ pain as intermittent, constant, or mixed using the Modified painDETECT Questionnaire and assessed associations with the variables using multinomial logistic regression. Results: The 279 participants had an average age of 63.8 years (SD = 9.6), BMI of 31.5 kg/m2 (SD = 8.7), and 58.6% were female. Older age (odds ratio [OR] 0.95; 95% CI: 0.90, 1.00) and higher self-reported physical function ([OR] 0.94; 95% CI: 0.91, 0.98) were associated with a lower likelihood of mixed pain compared with intermittent pain. Higher pain intensity ([OR] 1.25; 95% CI: 1.07, 1.47) was related to a 25% higher likelihood of mixed pain compared with intermittent pain. Conclusions: This study provides initial data for associations of personal, pain, and physical function factors with different pain patterns. Awareness of these factors can help clinicians develop targeted strategies for managing patients’ pain.


2006 ◽  
Vol 10 (S1) ◽  
pp. S241b-S241 ◽  
Author(s):  
J. Rejas ◽  
C. Pérez ◽  
R. Gálvez ◽  
J. Insausti ◽  
M. Bennet ◽  
...  

psychoneuro ◽  
2005 ◽  
Vol 31 (02) ◽  
pp. 103-105 ◽  
Author(s):  
Rainer Freynhagen
Keyword(s):  

Author(s):  
L. T. Maksymchuk ◽  
V. A. Gryb ◽  
O. O. Doroshenko ◽  
S. I. Genyk ◽  
V. R. Gerasymchuk ◽  
...  

The data of 61 medical cards of patients with multiple sclerosis has been analyzed. 47,54% of patients reported pain as a symptom of multiple sclerosis, following types of pain were observed: neuropathic pain (оngoing extremity pain, Lhermitte's phenomenon), nociceptive pain (headache, back pain) and mixed pain (painful tonic spasms, spasticity pain). Only 17,24% of patients received therapy to treat pain.


Der Hausarzt ◽  
2013 ◽  
Vol 50 (13) ◽  
pp. 49-49
Author(s):  
feb
Keyword(s):  

2016 ◽  
Vol 12 (3) ◽  
pp. 187
Author(s):  
Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA ◽  
Danielle M. Santarelli, PhD

Objective: To assess the effectiveness and tolerability of tapentadol sustained release (SR) following its introduction to the Australian private market.Design: A retrospective audit of routine clinical practice with data collection beginning 2 months after the first tapentadol SR prescription.Setting: A multidisciplinary Australian pain clinic.Patients: Fifty patients who were prescribed tapentadol SR as part of routine clinical management at the pain clinic.Interventions: Trial of tapentadol SR with subsequent dose titration if the patient was satisfied with or tolerant of the medication.Main outcome measures: Patient-reported pain outcome, side effects, medication adherence, and concomitant analgesic medications.Results: Sixty-eight percent of patients reported major reductions in pain. Seventy-two percent of patients tolerated and adhered to treatment and 76 percent reported no side effects. Pain outcome was independent of pain type and prior opioid exposure; however, patients taking tapentadol in combination were more likely to report a positive outcome (Pearson χ2 = 9.867, n = 46, p = 0.0072).Conclusions: Tapentadol was effective and generally well tolerated in the majority of patients for neuropathic, nociceptive and mixed pain types and this was regardless of prior opioid use.


Sign in / Sign up

Export Citation Format

Share Document